Simtuzumab (AB 0024, GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).
Purity:
98.5%
CAS Number:
[1318075-13-6]
Target:
Monoamine Oxidase
* VAT and and shipping costs not included. Errors and price changes excepted